Abstract
Asia-Pacific region bears a significant global burden of retinoblastoma (RB), therefore understanding RB in Asia-Pacific region is important. Based on the year 2013 population estimates, 43% (3452 of 8099 children) of the global burden of RB lives in 6 countries of Asia-Pacific region: 1486 children in India, 1103 children in China, 277 children in Indonesia, 260 children in Pakistan, 184 children in Bangladesh, 142 children in Philippines. There exists a wide disparity, technological and socio-economical, within countries in this region resulting in a varied pattern of clinical presentation and survival varies. Challenges in developing nations are not just technological, but also social. Opportunities emerge for research to study and understand the socio-economical aspects of the disease to develop interventions that are relevant culturally and feasible economically. Possible steps include disease education and counselling, universal screening, highly subsidized/free of cost treatment for low socioeconomic strata, raising funds through the government and non-governmental organizations, sensitization and training of man-power in screening, diagnosis and treatment, and developing new specialized centers with tele-ophthalmology services.
摘要
亚太地区是全球主要的视网膜母细胞瘤 (RB) 患病地区, 因此了解亚太地区RB的患病情况具有重要意义。根据2013年人口估计, 全球患RB儿童中的43%(8099名儿童中的3452名)生活在亚太地区的6个国家:印度1486名儿童、中国1103名儿童、印度尼西亚277名儿童、巴基斯坦260名儿童、孟加拉国184名儿童、菲律宾142名儿童。各国在技术和社会经济方面存在着巨大差异, 导致了临床表现和生存数量的不同。发展中国家面临的挑战不仅是技术方面的, 还有社会方面的。学习理解该疾病的社会经济方面的特点以制定与文化相关和经济可行性的干预措施很重要。可能采取的措施包括疾病的教育咨询、普遍筛查、对社会经济地位低的人群给予高补贴/免费治疗、通过政府和非政府组织筹集资金、提高筛查及诊断和治疗方面的人才的认识和培训, 以及发展具有远程眼科服务的新型专业中心。
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.
Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, et al. Retinoblastoma. Lancet. 2012;379:1436–46.
Kivelä T. 200 years of success initiated by James Wardrop’s 1809 monograph on retinoblastoma. Actaophthalmologica. 2009;8:810–2.
Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol & Vis Sci. 2005;46:2684–91.
Abramson DH, Beaverson K, Sangani P, Vora RA, Lee TC, Hochberg HM, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112:1248–55.
Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis Prim. 2015;1:15021.
Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122:e763–70.
Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:24–7.
MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 2009;93:38–9.
MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2092–102.
Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: survival and clinical characteristics 1978–2000. Jpn J Ophthalmol. 2002;46:577–80.
EN Gichigo, Kariuki-Wanyoike, Kimani MM, Nentwich K, Retinoblastoma MM. in Kenya: survival and prognostic factors. Ophthalmologe. 2015;112:255–60.
Goolam S, Kana H, Welsh N, Wainwright L, Poole J, Mayet I. A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa. Ocul Oncol Pathol. 2018;4:170–5.
Prasad Sah K, Saiju R, Roy P, Kafle S Retinoblastoma: ten years experience at Kanti Children’s Hospital. Journal of the Nepal Medical Association. 2013;52:576–9.
Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94:1432–6.
Chawla B, Kumar K, Singh AD. Influence of socioeconomic and cultural factors on retinoblastoma management. Asia Pac J Oncol Nurs. 2017;4:187.
Usmanov RH, Kivelä T. Predicted trends in the incidence of retinoblastoma in the Asia-Pacific region. Asia-Pac J Ophthalmol. 2014;3:151–7.
Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015;100:172–8.
Kaliki, S., Patel, A., Iram, S., Ramappa, G., Mohamed, A., & Palkonda, V. A. R. (2017). RETINOBLASTOMA IN INDIA. Retina, 1. https://doi.org/10.1097/iae.0000000000001962
Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R. Retinoblastoma: a sixteen-year review of the presentation, treatment, and outcome from a tertiary care institute in Northern India. Ocul Oncol Pathol. 2018;4:23–32.
Shah PK, Narendran V, Kalpana N. Outcomes of intra-and extraocular retinoblastomas from a single institute in South India. Ophthalmic Genet. 2015;36:248–50.
Kaliki S, Shields CL, Eagle JR, Iram S, Shields JA. High-risk intraocular retinoblastoma: comparison between Asian Indians and Americans from two major referral centers. Retina. 2017;38:2023–9.
Kaliki S, Patel A, Iram S, Palkonda VA. Clinical presentation and outcomes of stage III or stage IV retinoblastoma in 80 Asian Indian patients. J Pediatr Ophthalmol Strabismus. 2017;54:177–84.
Kiratli PÖ, Kiratli H, Ercan MT. Visualization of orbital retinoblastoma with technetium-99m (V) dimercaptosuccinic acid. Ann Nucl Med. 1998;12:157–9.
Moll AC, Hoekstra OS, Imhof SM, Comans EF, Meeteren AS, van der Valk P, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalmic Genet. 2004;25:31–5.
Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol. 2003;40:158–61.
Chantada GL, Guitter MR, Fandiño AC, Raslawski EC, de Davila MT, Vaiani E, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer. 2009;52:218–22.
Honavar SG, Manjandavida FP, Reddy VA. Orbital retinoblastoma: An update. Indian J Ophthalmol. 2017;65:435.
Ali MJ, Honavar SG, Reddy VA. Orbital retinoblastoma: Present status and future challenges–A review. Saudi J Ophthalmol. 2011;25:159–67.
Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, et al. Multimodal therapy for stage III retinoblastoma (International Retinoblastoma Staging System): A prospective comparative study. Ophthalmology. 2016;123:1933–9.
Wiangnon S, Veerakul G, Nuchprayoon I, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12:2215–20.
Wongmas P, Jetsrisuparb A, Komvilaisak P, et al. Incidences, trends and long term outcomes of retinoblastoma in three cancer registries, Thailand. Asian Pac J Cancer Prev. 2015;16:6899–902.
Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol. 2009;53:35–9.
Aung L, Chan YH, Yeoh EJ, Tan PL, Quah TC. Retinoblastoma: a recent experience at the National University Hospital, Singapore. Ann Acad Med Singap. 2009;38:693–8.
Chantada G, Doz F, Antoneli CBG, et al. A proposal for an International retinoblastoma staging system. Pediatr Blood Cancer. 2006;47:801–5.
Jeyabal P, Sundar G. Anophthalmic sockets in retinoblastoma: a single center experience. Asia Pac J Ophthalmol. 2018. https://doi.org/10.22608/APO.201892.
Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci. 1971;68:820–3.
Leander C, Fu LC, Pena A, Howard SC, Rodriguez‐Galindo C, Wilimas JA, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007;49:817–9.
Borooah VK. Gender bias among children in India in their diet and immunisation against disease. Soc Sci Med. 2004;58:1719–31.
Pillay-van Wyk V, Bradshaw D. Mortality and socioeconomic status: the vicious cycle between poverty and ill health. Lancet Glob Health. 2017;5:e851–2.
Ellsworth RM. Orbital retinoblastoma. Trans Am Ophthalmol Soc. 1974;72:79.
Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematology/Oncology. Clinics. 1987;1:721–35.
Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005;33:386–9.
Gündüz K, Müftüoglu O, Günalp I, Ünal E, Taçyıldız N. Metastatic retinoblastoma: clinical features, treatment, and prognosis. Ophthalmology. 2006;113:1558–66.
Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015;100:172–6.
Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40:265.
Elzomor H, Taha H, Nour R, Aleieldin A, Zaghloul MS, Qaddoumi I, et al. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. Ophthalmic Genet. 2017;38:345–51.
Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet. 2009;30:31–6.
Olteanu C, Dimaras H. Enucleation refusal for retinoblastoma: a global study. Ophthalmic Genet. 2016;37:137–43.
Austoker J, Bankhead C, Forbes LJ, Atkins L, Martin F, Robb K, et al. Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer. 2009;101(S2):31.
Acknowledgements
We acknowledge our colleauges at Sankara Netharalaya (Chennai), Dr. Rajendra Prasad Centre for Ophthalmic Sciences (AIIMS, New Delhi), National University Hospital (National University of Singapore, Singapore) and Ramathibodi Hospital (Mahidol University Faculty of Medicine, Bangkok, Thailand) for their support and guidance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Jain, M., Rojanaporn, D., Chawla, B. et al. Retinoblastoma in Asia. Eye 33, 87–96 (2019). https://doi.org/10.1038/s41433-018-0244-7
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41433-018-0244-7
This article is cited by
-
Tumor heterogeneity in retinoblastoma: a literature review
Cancer and Metastasis Reviews (2025)
-
Investigation of GD2 synthase as a potential marker for retinoblastoma poor prognosis
Molecular Biology Reports (2025)
-
Quality of life among people with eye cancer: a systematic review from 2012 to 2022
Health and Quality of Life Outcomes (2024)
-
Retinoblastoma patients treated in Sri Lanka from 2014 to 2020: epidemiology, clinical status and correlates of lag time in seeking tertiary care services
BMC Ophthalmology (2024)
-
Clinical characteristics, treatment and prognosis of infants with retinoblastoma: a multicenter, 10-year retrospective analysis
BMC Pediatrics (2023)
